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Introduction 
 Artificial sweeteners remain a controversial topic despite their prevalence in our foods. 
Artificial sweeteners are used as sugar substitutes or sugar alternatives in foods, beverages and/or 
sweetener packets. There are several types of artificial sweeteners including sugar alcohols, 
nutritive sweeteners, nonnutritive sweeteners and dietary supplements. The most commonly 
discussed and controversial type of sweetener is the nonnutritive sweetener (NNS). NNSs are 
also known as high-intensity sweeteners or low-calorie sweeteners, because they are many times 
sweeter than sugar and therefore contribute little to no calories. Replacing sugar with a NNS 
makes a food or beverage become less energy dense which is why many health professionals 
have encouraged the use of NNSs for patients on weight-loss or weight-maintenance programs. 
The theory is that consuming food sweetened with NNS instead of sugar will result in a lower 
daily energy intake and help patients or clients adhere to their diet plans.1  
 The prevalence of NNS in food products has risen steadily in past decades for economic 
reasons and in response to diet trends.2 Manufacturers can save money by using NNS in their 
products since only a small amount is needed compared to sugar for the same sweet taste. Diet 
trends are steering away from added sugars and rely on NNS or other sweeteners to maintain the 
sweet taste needed for certain foods. Recent legislation will require several changes to the 
Nutrition Facts Label. As of January 1, 2020, Nutrition Facts Labels will be required to include 
the amount of added sugar in the food.3 This will be another motivating factor for manufacturers 
to replace sugar with NNS or other sugar alternatives. According to one study, over 6,000 new 
foods and beverages containing NNS were introduced to the United States between the years 
1999 and 2004.2  
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 As the prevalence and consumption of NNS increases, the public concern of possible 
adverse effects seems to rise as well. Until recently, NNS were regarded as a useful tool in 
decreasing energy and sugar intake and supporting a goal of weight management, weight loss, 
and/or glycemic blood control.4 However, recent studies have shown that there is not a 
significant correlation between NNS use and weight loss.5,6 Several observational studies have 
shown that NNS consumption is associated with increased BMI and weight gain.5-8 This review 
of literature aims to examine the prevalence, consumption and overall effects of nonnutritive 
sweeteners on human health. 
Consumption of Nonnutritive Sweeteners 
 Consumption of nonnutritive sweeteners has been increasing for decades according to the 
National Health and Nutrition Examination Survey (NHANES). One meta-analysis determined 
that 30% of Americans reported daily use of NNS in 2008.5 The 2001-2002 NHANES study 
reported that the national average consumption of NNS was 24%. The 2007-2008 NHANES 
study reported that the national average NNS consumption increased to 28%.8 Dietary data is 
collected for the NHANES surveys using two 24-hour diet recalls. The first diet recall is 
obtained through an in-person interview and the second diet recall is recorded over the phone 3-
10 days after the in-person interview.8 It is important to note that consumption rates also vary 
across regions of the United States. A study that focused on the NNS consumption by rural 
Virginian residents showed that 33% of the participants consumed NNS which is higher than the 
estimated national average.7 Rural Virginia was an important research area because rural 
populations are more health-disparate, have a higher prevalence of obesity and related health 
complications.7 There was no determined significance of the correlation of higher rates of 
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obesity, health disparity, and higher consumption of NNS, but this information may be helpful in 
future studies. 
  Another recent study analyzing data from two cycles of the cross-sectional NHANES 
studies was conducted with a total sample size of 16,986 participants. Consumption rates 
differed among sociodemographic populations. Previous studies have shown that NNS 
consumption rates increase with income status, weight status, and age. Females also have a 
higher consumption rate of NNS. Sylvetsky and colleagues sought to determine difference in 
NNS consumption depending on circumstance of an individual and their environment. The 
researchers also wanted to categorize the source of NNS consumption. Results revealed that 70% 
of NNS were consumed in the participant’s home. In addition, 41.4% of adults consumed NNS at 
least one of the two days of food recall, and 25.1% of children consumed NNS on at least one 
day of the food recall. The researchers also categorized the intake by source and found that 
30.8% of adult intake came from beverages, 10.3% from foods, and 14.1% from sweetener 
packets. The collected data also showed that 64% of adults and 62% of children consumed NNS 
as part of a meal. When compared to overall food intake, the proportion of NNS-containing 
foods was relatively low. For example, only 1-2.5% of all desserts consumed in NHANES 2009-
2012 contained NNS. However, the proportion of NNS-containing yogurt was more significant 
with 25% of yogurt consumed by adults containing NNS.6 Understanding which subgroups of 
the population have higher use of NNS, and the etiology of higher use, will help shape future 
studies and planned interventions regarding the possible health effects.8 
Approved Nonnutritive Sweeteners 
 In the United States, the Food and Drug Administration (FDA) regulates and approves all 
added food ingredients.3 NNS is regulated as a food additive and therefore must undergo 
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premarket review and receive FDA approval before it can be used in foods. An exception to this 
approval process occurs if a NNS is only to be used as a sweetener and not as a food ingredient. 
Instead of needing to go through the FDA approval process, it can be deemed generally 
recognized as safe (GRAS). A GRAS substance is not required to get premarket approval. A 
company can determine a food GRAS without notifying the FDA if a qualified expert with 
scientific training has concluded that the substance is safe. Scientists and experts are involved in 
both FDA and GRAS approval processes. The FDA approval or determined GRAS means there 
is a “reasonable certainty that a substance is not harmful under the intended conditions of use.”3 
 There are currently six NNS approved for use in the United States. These include 
acesulfame potassium (Ace-K), advantame, aspartame, neotame, saccharin, and sucralose. Each 
NNS has a different Acceptable Daily Intake (ADI) because they have different chemical 
compositions and are metabolized differently in the human body.9 The metabolic processes, 
research, and general use of each NNS will be discussed further in the next section.  
How Nonnutritive Sweeteners are Metabolized and their Acceptable Daily Intake 
 Rolfes and colleagues state, “[c]onsidering that all substances are toxic at some dose, it is 
little surprise that large doses of artificial sweeteners (or their components or metabolic by-
products) may have adverse effects.”1 The important question to ask is whether NNSs are safe 
for human ingestion in the amounts that they are likely to consume. The way the human body 
responds to the chemical composition of artificial sweeteners is also important to understanding 
the possible effects on human health. Nonnutritive sweeteners provide very little energy because 
the body does not digest or absorb the sweetener or sweetener components.1 
• Acesulfame potassium (Ace-K): Ace-K is composed of potassium salt and is not digested 
or absorbed by the human body. It is 200 times sweeter than sucrose (sugar) and 
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contributes 0 kcal/g.1 Ace-K is often mixed with other sweeteners and is heat stable 
making it perfect for use in baked goods. There are more than 90 studies that support the 
safety of Ace-K consumption.3 The current Acceptable Daily Intake (ADI) is 15mg/kg 
body weight, or 30 cans of diet soda.1  
• Advantame: Advantame is the most recent non-nutritive sweetener to be approved in 
2014. It is about 20,000 times sweeter than sucrose and is approved for use as a general-
purpose sweetener under certain conditions. Advantame is heat stable and thus makes a 
good sugar substitute in baked goods. The FDA determined that advantame was safe to 
consume after reviewing data from 37 animal and human studies.3 The Academy of 
Nutrition and Dietetics (AND) has not yet issued a conclusion statement on this 
sweetener.9  
• Aspartame: Aspartame is composed of a methyl group and the amino acids phenylamine 
and aspartic acid. It is digested and absorbed by the human body and is 200 times sweeter 
than sucrose. Aspartame can be categorized as a nonnutritive or nutritive sweetener.1,3 
Alone it provides 0 kcal/g, however in powdered form it is typically mixed with lactose 
and thus provides 4 kcal/g.1 The FDA first approved aspartame for use in 1981 under 
certain conditions and eventually expanded the approval to “general purpose sweetener” 
in 1996.3 Aspartame is the most extensively studied sweetener used in the human food 
supply, with over 100 studies declaring that it is safe for human consumption. Although it 
has been determined that the general population can consume aspartame without 
significant health effects, people with the rare hereditary disease phenylketonuria (PKU) 
cannot consume aspartame safely. Those who are diagnosed with phenylketonuria cannot 
efficiently metabolize the amino acid phenylalanine, which is a component of aspartame. 
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Consumption of aspartame can therefore lead to a toxic buildup of phenylalanine in 
individuals with PKU. The FDA requires foods and beverages containing aspartame to 
include a warning labels for consumers with PKU.3 The current ADI for the healthy 
population is 50mg/kg body weight, or 18 cans of diet soda.1  
• Neotame: Neotame is aspartame with an additional side group attached. It is also not 
digested or absorbed by the human body. The additional side group makes this NNS 
about 8,000 times sweeter than sucrose. The ADI is 18mg/day. No warning label is 
needed for PKU consumers. Due to the intense sweetness of neotame, there is a 
negligible amount of phenylalanine broken down in the body.1 Neotame was first 
approved by the FDA in 2002 as a general-purpose sweetener and flavor enhancer in all 
foods, except in meat and poultry. The FDA reviewed 113 animal and human studies to 
evaluate possible toxic effects of neotame before approval.3 
• Saccharin: Saccharin is composed of benzoic sulfimide which is rapidly absorbed and 
excreted by the human body. It is 450 times sweeter than sucrose and the ADI is 5mg/kg 
body weight, or about 10 packets of the sweetener. Saccharin was first discovered in 
1879 and has been used in food and beverage products since that time. However, in the 
1970s several research studies linked dietary saccharin intake with the development of 
bladder cancer in laboratory rats. Congress mandated that products containing saccharin 
have a warning label until the year 2000. The National Institute of Health concluded that 
saccharin was safe for human consumption and removed the sweetener from the potential 
carcinogen list because the metabolic pathway that linked saccharin to bladder cancer in 
rats is completely different in humans. This is a great example of why animal studies are 
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not a gold standard of research by any means. The same adverse effects of saccharin have 
not been replicated in humans to date.3 
• Sucralose: Sucralose is sucrose with chlorine (Cl) atoms in place of hydroxyl groups 
(OH). Most of sucralose is not digested or absorbed by the human body (85%) and is 
excreted unchanged in the urine.7 Sucralose provides 0 kcal/g. It is approved for use in 
both the United States and Canada and sold under the brand name Splenda. Sucralose is 
approximately 600 times sweeter than sucrose. The ADI is 5 mg/kg body weight, or 
about 6 cans of diet soda.1 Sucralose was approved for use as a general-purpose 
sweetener in 1999 and is commonly found in beverages, chewing gum, and frozen dairy 
desserts. It is heat stable making it suitable for baking and used regularly in baked goods. 
The FDA reviewed over 110 studies before determining the safety of sucralose use in 
food.3 AND, in its review of related research, also determined the safety of sucralose 
consumption. However, every conclusion statement made by the Evidence-based 
Analysis Library (EAL) has been given a Grade III (Limited) due to limited evidence.9 
Nonnutritive Sweeteners and Potential Health Effects 
 The researchers of one study aimed to determine whether continuous consumption of 
NNS by adults and adolescents were associated with long-term adverse cardiometabolic effects. 
Azad and his colleagues noted that a previous meta-analysis reported conflicting evidence 
between randomized control trials (RCTs) and observational studies. Various RCTs analyzed 
whether NNS consumption had weight loss effects and determined a positive association 
between NNS intake and weight loss. However, observational studies have reported a slight 
increase in body mass index (BMI) after long-term consumption of NNS.5 
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 Azad and his colleagues looked at both RCT and prospective cohort studies to determine 
the long-term effects of NNS on health. Various health outcomes aside from body composition 
were used. To be included in the meta-analysis, the studies had to have a minimum study 
duration of 6 months, and the participants had to be at least 12 years old. A total of 7 RCTs and 
30 cohort studies met the criteria, resulting in a total of 406,910 study participants.5 
 The primary outcome observed in this study was change in BMI, and the secondary 
outcomes included change in body weight, adiposity, glucose metabolism, and diagnosis of 
metabolic syndrome. The cohort studies found an association between the routine intake of NNS 
and an increased risk of obesity, hypertension, metabolic syndrome, and stroke. However, it is 
important to note that results of cohort studies cannot always be replicated in clinical trials and 
are therefore not considered evidence-based.5 
Metabolic Effects of Nonnutritive Sweeteners 
 Other researchers studied the potential mechanisms that may make NNSs metabolically 
active and potentially lead to adverse metabolic effects.6 Miller and Perez conducted a systematic 
literature review in which they examined what the evidence was regarding the effect of NNS on 
three metabolic mechanisms. These mechanisms included learned responses by the human body 
that contributed to glucose homeostasis, the effect NNS had on gut microbacteria, and the 
interaction of NNS on sweet-taste receptors with insulin secretin triggers. Until recently there 
was a general understanding that NNS was a healthy alternative to sugar and was metabolically 
inactive. NNS was also believed to provide a sweet taste without the glycemic effects and added 
calories of sugar. However, recent studies have associated NNS consumption with adverse 
metabolic effects and weight gain.6 
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 Miller and Perez discussed two hypotheses for the recent association between NNS intake 
and metabolic effects. First, those results could be due to reverse causation. Overweight and 
obese individuals have a higher consumption rate of NNS, but the cause and effect is not certain. 
It is possible that overweight individuals who are more likely to have metabolic disorders 
without NNS consumption have a higher intake because they are trying to use NNS to manage 
their weight. The second hypothesis is that contrary to popular belief, NNS are metabolically 
active and affect biological processes involved with energy and glucose regulation.6 
 Studies conducted on animal subjects have shown that consuming NNS results in heavier 
mice with reduced thermic responses to food. However, these results cannot be compared to 
humans due to the differences in digestion mechanisms. Humans, unlike mice, have learned 
responses that influence glucose and energy homeostasis. Therefore, future studies need to 
examine learned responses in humans to obtain more accurate data results.6 
 One definitive benefit of NNS intake is the reduction in dental cavities compared to 
regular sugar intake. NNS are resistant to fermentation and can stop bacteria from reproducing. 
While this is beneficial to the health of the human mouth, it may be detrimental to the gut. Gut 
microbacteria is essential to human health, and NNS may reduce the body’s “good” bacteria that 
fights off the “bad” bacteria.6 
 Overall, human studies on the potential metabolic effects of NNS are limited. Only two 
of the mechanisms of Pepino’s study have been researched in humans.4 One considered 
mechanism was whether NNS triggers glucose intolerance by changing gut microbacteria. The 
study of effects on the human body’s gut microbiome is limited to saccharin, which is only one 
of six NNS currently approved as a food additive. The second mechanism studied in humans is 
whether the recently found sweet taste receptors located in the gut and pancreas can influence 
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insulin secretion. There are too many inconsistencies in the data results in sweet taste receptors 
studies to adequately determine any effects.4 Further studies must be done on human subjects to 
determine and understand the metabolic mechanisms and potential effects of NNS consumption 
on human health.6 
NNS as a Useful Dietary Tool 
 A meta-analysis conducted by Miller and Perez aimed to evaluate the association 
between NNS, body weight and composition. The reason that these researchers decided to focus 
on body weight and composition is because of the obesity prevalence. They wished to determine 
the safety of NNS consumption as a dietary tool to help people maintain or lose excess weight. 
The authors systematically reviewed and quantitatively evaluated 15 RCTs and 9 prospective 
cohorts. There was a total of 1,951 participants across all examined studies. The minimum study 
duration for RCTs was 2 weeks, and the minimum for the cohort studies was 6 months. They 
found a small association between increased BMI and NNS consumption in the prospective 
cohort studies, but no association with increased body weight. The RCTs indicated that 
substituting NNS for sugar reduced body weight, BMI, fat mass and waist circumference. The 
two types of studies contradicted each other on the BMI outcomes of participants, but RCTs are 
the gold standard in research design. Therefore, Miller and Perez concluded that NNS could be a 
safe, useful tool in managing body weight.6  
Limitations of NNS Research 
 A limitation in all artificial sweetener consumption studies is the difficulty of quantifying 
the amount of artificial sweetener in a product. With the exception of saccharin, manufacturers 
are not required to disclose the quantity of added artificial sweeteners on product labels. Another 
limitation to the cross-sectional studies are the reliance on diet recalls which provide subjective 
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data and may not be accurate. Therefore, the amount of artificial sweetener intake is an 
unreliable estimation.8    
The Position of the Academy of Nutrition and Dietetics on Nonnutritive Sweetener Use 
 The AND routinely reviews and analyzes research to determine their safety and to create 
guidelines for human consumption of artificial sweeteners. A systematic review utilizing data 
collected from the EAL is used in determining the guidelines. It is the position of AND that 
consumers can safely ingest the artificial sweeteners that have been approved by the FDA as 
long as the consumption follows the ADI guidelines. Currently there are 6 nonnutritive 
sweeteners approved by the FDA, each with a different ADI. Artificial sweeteners are shown to 
be effective in weight loss management by reducing energy intake. They are approved for use in 
those who have diabetes since they are a safe alternative to sugar. There is also evidence to 
suggest that artificial sweeteners can reduce dental cavities by inhibiting bacteria growth. For 
these reasons, the AND approves the use of artificial sweeteners.9 
Limitations of the EAL  
 The limitations to the method used for the EAL include the amount of artificial sweetener 
studies that meet criteria. Once a conclusion has been reached about a research question, the 
conclusion statement is graded based upon the strength of the supporting evidence and analysis. 
It is important to note that many of the EAL conclusions made by the Nutritive and Non-
Nutritive Sweeteners (NNNS) workgroup are graded as a III, which means there is “Limited” 
evidence to support them. Also, many of the conclusions have not been updated since 2006, and 
the use of artificial sweeteners has increased since then. Another important aspect to note is the 
funding sources of the NNNS workgroup include the Coca-Cola Company. This may be a 
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potential conflict considering the profits that Coca-Cola earns from selling diet sodas sweetened 
with artificial sweeteners.9 
Conclusion 
 Although NNSs have been used in foods for decades now, controversy remains on the 
overall effects of these substances on human health. NNS have generally been used as a calorie-
free replacement for sugar, which can make food items less energy dense. Healthcare 
professionals have supported the consumption of foods sweetened with NNS as part of a weight 
loss or weight maintenance program. However, recent studies have not supported the previous 
claim that consumption of NNS can help with significant weight loss. Past RCTs have found an 
association of NNS consumption and reduced body weight, reduced fat mass, and reduced BMI. 
On the contrary, epidemiological studies have associated NNS consumption with an increase in 
BMI.5  
 The limitations of past research studies that focused on NNS prevalence and consumption 
should be addressed. One of the biggest limitations in most dietary studies is the error of self-
reported diets.8 The accuracy of dietary studies of NNS consumption is hindered even further 
because food manufacturers do not have to include the amount of NNS in their product.3,8 
Researchers, professionals and consumers should advocate for policy reform on this issue so that 
the public can be better informed and researchers can work with a more reliable database.  
 The goal of this paper was to evaluate the prevalence, consumption and overall effects of 
NNSs. Most research on NNSs has focused on body weight and composition as the outcome of 
the study. Other outcomes have included risk of obesity and other metabolic effects such as 
hypertension, metabolic syndrome and stroke. Research consistently shows conflicting evidence 
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between RCTs and epidemiological observational studies on the metabolic outcomes of NNS 
consumers.  
 The prevalence and consumption of NNS has been on the rise, but the research has not 
kept pace. RCTs are the gold standard of research studies, and most of these studies have not 
shown significant results in any short-term metabolic effects. However, there have been no RCTs 
conducted to study the long-term effects of NNS. Although the prevalence of NNS consumption 
has increased, the amount of research studies done about NNS effects have not. It is difficult to 
find studies conducted within the past 10 years. In fact, the most referenced RCT by peer-
reviewed journal articles was published in 1997.10 More research needs to be done to investigate 
potential long-term effects of NNS and to evaluate whether the possible weight loss benefits of 
NNS is maintainable long-term. 
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